Frenkel, J. Et Al. 2016. Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial. ARTHRITIS & RHEUMATOLOGY , vol.68 .

Frenkel, J., Anton, J., Livneh, A., Ben-Chetrit, E., Brogans, P., Bujan-Rivas, S., ... Constantin, M.(2016). Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial. ARTHRITIS & RHEUMATOLOGY , vol.68.

Frenkel, Joost Et Al. "Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial," ARTHRITIS & RHEUMATOLOGY , vol.68, 2016

Frenkel, Joost Et Al. "Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial." ARTHRITIS & RHEUMATOLOGY , vol.68, 2016

Frenkel, J. Et Al. (2016) . "Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial." ARTHRITIS & RHEUMATOLOGY , vol.68.

@article{article, author={Joost Frenkel Et Al. }, title={Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2016}